Suppression of Human Liver Cancer Cell Migration and Invasion via the GABAA Receptor

Objective To investigate the roles of the γ-aminobutyric acid (GABA) in the metastasis of hepatocellular carcinoma (HCC) and to explore the potential of a novel therapeutic approach for the treatment of HCC. Methods The expression levels of GABA receptor subunit genes in various HCC cell lines and patients‘ tissues were detected by quantitative real-time polymerase chain reaction and Western blot analysis. Transwell cell migration and invasion assays were carried out for functional analysis. The effects of GABA on liver cancer cell cytoskeletal were determined by immunofluorescence staining. And the effects of GABA on HCC metastasis in nude mice were evaluated using an in vivo orthotopic model of liver cancer. Results The mRNA level of GABA receptor subunits varied between the primary hepatocellular carcinoma tissue and the adjacent non-tumor liver tissue. GABA inhibited human liver cancer cell migration and invasion via the ionotropic GABAA receptor as a result of the induction of liver cancer cell cytoskeletal reorganization. Pretreatment with GABA also significantly reduced intrahepatic liver metastasis and primary tumor formation in vivo. Conclusions These findings introduce a potential and novel therapeutic approach for the treatment of cancer patients based on the modulation of the GABAergic system.

[1]  M. Ullah,et al.  Gamma-amino butyric acid inhibits the nicotine-imposed stimulatory challenge in xenograft models of non-small cell lung carcinoma. , 2012, Current cancer drug targets.

[2]  A. Sood,et al.  Inhibition of experimental colon cancer metastasis by the GABA-receptor agonist nembutal , 2005, Cancer biology & therapy.

[3]  Tao Wang,et al.  Baclofen, a GABAB receptor agonist, inhibits human hepatocellular carcinoma cell growth in vitro and in vivo. , 2008, Life sciences.

[4]  Yusuke Nakamura,et al.  Gamma-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor pi subunit. , 2007, Cancer research.

[5]  Kerstin Lang,et al.  Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters. , 2004, The Lancet. Oncology.

[6]  T. Patel,et al.  gamma-Aminobutyric acid inhibits cholangiocarcinoma growth by cyclic AMP-dependent regulation of the protein kinase A/extracellular signal-regulated kinase 1/2 pathway. , 2005, Cancer research.

[7]  H. Dienes,et al.  Decreased hepatocyte membrane potential differences and GABAa‐β3 expression in human hepatocellular carcinoma , 2007, Hepatology.

[8]  H. Plummer,et al.  Regulation of pancreatic cancer by neuropsychological stress responses: a novel target for intervention. , 2012, Carcinogenesis.

[9]  K. Takahara,et al.  Gamma-aminobutyric acid as a promoting factor of cancer metastasis; induction of matrix metalloproteinase production is potentially its underlying mechanism. , 2003, Cancer research.

[10]  G. Minuk,et al.  Sodium-independent, bicuculline-sensitive [3H]GABA binding to isolated rat hepatocytes. , 1987, The American journal of physiology.

[11]  Z. Tang,et al.  Hepatocellular carcinoma--cause, treatment and metastasis. , 2001, World journal of gastroenterology.

[12]  Masahito Watanabe,et al.  Proliferative effects of γ‐aminobutyric acid on the gastric cancer cell line are associated with extracellular signal‐regulated kinase 1/2 activation , 2009, Journal of gastroenterology and hepatology.

[13]  H. Plummer,et al.  Nicotine stimulates pancreatic cancer xenografts by systemic increase in stress neurotransmitters and suppression of the inhibitory neurotransmitter gamma-aminobutyric acid. , 2009, Carcinogenesis.

[14]  G. Klintmalm,et al.  Liver transplantation for primary and metastatic liver cancers. , 1997, Annals of transplantation.

[15]  H. Schuller,et al.  Gamma-aminobutyric acid, a potential tumor suppressor for small airway-derived lung adenocarcinoma , 2008, Carcinogenesis.

[16]  Masahito Watanabe,et al.  GABA and GABA receptors in the central nervous system and other organs. , 2002, International review of cytology.

[17]  G. Johnston.  GABAA receptor pharmacology. , 1996, Pharmacology & therapeutics.

[18]  H. El‐Serag,et al.  Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. , 2007, Gastroenterology.

[19]  Arnold R. Kriegstein,et al.  Is there more to gaba than synaptic inhibition? , 2002, Nature Reviews Neuroscience.

[20]  H. Schuller,et al.  GABAB receptor is a novel drug target for pancreatic cancer , 2008, Cancer.

[21]  F. Entschladen,et al.  The neurotransmitter gamma-aminobutyric acid is an inhibitory regulator for the migration of SW 480 colon carcinoma cells. , 2002, Cancer research.

[22]  R. Lencioni,et al.  Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved? , 2010, The oncologist.

[23]  H. Plummer,et al.  Social Stress Promotes and γ-Aminobutyric Acid Inhibits Tumor Growth in Mouse Models of Non–Small Cell Lung Cancer , 2011, Cancer Prevention Research.

[24]  Jian Yu,et al.  Large-scale cDNA transfection screening for genes related to cancer development and progression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Y. Shibayama,et al.  Gamma-aminobutyric acid (GABA) and cell proliferation: focus on cancer cells. , 2006, Histology and histopathology.

[26]  R. Sun,et al.  Gamma-aminobutyric acid promotes human hepatocellular carcinoma growth through overexpressed gamma-aminobutyric acid A receptor α3 subunit , 2008 .

[27]  E. Kirkness,et al.  Insensitivity to anaesthetic agents conferred by a class of GABAA receptor subunit , 1997, Nature.

[28]  Guan-Cheng Li,et al.  Gamma-aminobutyric acid promotes human hepatocellular carcinoma growth through overexpressed gamma-aminobutyric acid A receptor alpha 3 subunit. , 2008, World journal of gastroenterology.

[29]  Yusuke Nakamura,et al.  γ-Aminobutyric Acid (GABA) Stimulates Pancreatic Cancer Growth through Overexpressing GABAA Receptor π Subunit , 2007 .

[30]  J. Thiery,et al.  Complex networks orchestrate epithelial–mesenchymal transitions , 2006, Nature Reviews Molecular Cell Biology.

[31]  F. Entschladen,et al.  The Neurotransmitter γ-Aminobutyric Acid Is an Inhibitory Regulator for the Migration of SW 480 Colon Carcinoma Cells , 2002 .

[32]  Jacques Ferlay,et al.  Estimating the world cancer burden: Globocan 2000 , 2001, International journal of cancer.

[33]  Mary J. C. Hendrix,et al.  Role of intermediate filaments in migration, invasion and metastasis , 1996, Cancer and Metastasis Reviews.

[34]  Raghu Kalluri,et al.  The epithelial–mesenchymal transition: new insights in signaling, development, and disease , 2006, The Journal of cell biology.

[35]  N. Assy,et al.  Increased GABAergic activity inhibits alpha-fetoprotein mRNA expression and the proliferative activity of the HepG2 human hepatocellular carcinoma cell line. , 2000, Journal of hepatology.

[36]  K. Takahara,et al.  γ-Aminobutyric Acid as a Promoting Factor of Cancer Metastasis; Induction of Matrix Metalloproteinase Production Is Potentially Its Underlying Mechanism , 2003 .

[37]  Ming Yao,et al.  MicroRNA‐30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma , 2010, Hepatology.